NO120035B - - Google Patents
Download PDFInfo
- Publication number
- NO120035B NO120035B NO246169A NO246169A NO120035B NO 120035 B NO120035 B NO 120035B NO 246169 A NO246169 A NO 246169A NO 246169 A NO246169 A NO 246169A NO 120035 B NO120035 B NO 120035B
- Authority
- NO
- Norway
- Prior art keywords
- ethanol
- semicarbazide
- propanone
- imidazolyl
- nitro
- Prior art date
Links
- 150000003839 salts Chemical class 0.000 claims description 5
- 125000003545 alkoxy group Chemical group 0.000 claims description 4
- DUIOPKIIICUYRZ-UHFFFAOYSA-N semicarbazide Chemical compound NNC(N)=O DUIOPKIIICUYRZ-UHFFFAOYSA-N 0.000 claims description 4
- 229910052739 hydrogen Inorganic materials 0.000 claims description 2
- 239000001257 hydrogen Substances 0.000 claims description 2
- 125000004435 hydrogen atom Chemical class [H]* 0.000 claims description 2
- 150000002460 imidazoles Chemical class 0.000 claims description 2
- 229940079865 intestinal antiinfectives imidazole derivative Drugs 0.000 claims description 2
- 150000002576 ketones Chemical class 0.000 claims description 2
- 238000000034 method Methods 0.000 claims description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 16
- 239000000243 solution Substances 0.000 description 6
- 238000009835 boiling Methods 0.000 description 5
- 238000003756 stirring Methods 0.000 description 5
- BDKLKNJTMLIAFE-UHFFFAOYSA-N 2-(3-fluorophenyl)-1,3-oxazole-4-carbaldehyde Chemical compound FC1=CC=CC(C=2OC=C(C=O)N=2)=C1 BDKLKNJTMLIAFE-UHFFFAOYSA-N 0.000 description 4
- -1 Histomonacids Substances 0.000 description 4
- 150000001875 compounds Chemical class 0.000 description 4
- 238000002844 melting Methods 0.000 description 4
- 230000008018 melting Effects 0.000 description 4
- 235000017281 sodium acetate Nutrition 0.000 description 4
- 229940087562 sodium acetate trihydrate Drugs 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- UJTTUOLQLCQZEA-UHFFFAOYSA-N 9h-fluoren-9-ylmethyl n-(4-hydroxybutyl)carbamate Chemical compound C1=CC=C2C(COC(=O)NCCCCO)C3=CC=CC=C3C2=C1 UJTTUOLQLCQZEA-UHFFFAOYSA-N 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 3
- 238000000354 decomposition reaction Methods 0.000 description 3
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 238000001953 recrystallisation Methods 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- ZPGYOXBQOZVFQY-UHFFFAOYSA-N 1-(2-chloroethoxy)-3-(2-nitroimidazol-1-yl)propan-2-one Chemical compound [N+](=O)([O-])C=1N(C=CN1)CC(COCCCl)=O ZPGYOXBQOZVFQY-UHFFFAOYSA-N 0.000 description 1
- FPCFEEMMMCHLBI-UHFFFAOYSA-N 1-(2-nitroimidazol-1-yl)propan-2-one Chemical compound CC(=O)CN1C=CN=C1[N+]([O-])=O FPCFEEMMMCHLBI-UHFFFAOYSA-N 0.000 description 1
- VQSYAQVEKOTYCZ-UHFFFAOYSA-N 1-methoxy-3-(2-nitroimidazol-1-yl)propan-2-one Chemical compound COCC(=O)CN1C=CN=C1[N+]([O-])=O VQSYAQVEKOTYCZ-UHFFFAOYSA-N 0.000 description 1
- BMYNFMYTOJXKLE-UHFFFAOYSA-N 3-azaniumyl-2-hydroxypropanoate Chemical compound NCC(O)C(O)=O BMYNFMYTOJXKLE-UHFFFAOYSA-N 0.000 description 1
- 244000215068 Acacia senegal Species 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- 208000000230 African Trypanosomiasis Diseases 0.000 description 1
- 206010001935 American trypanosomiasis Diseases 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- 206010017533 Fungal infection Diseases 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 229920000084 Gum arabic Polymers 0.000 description 1
- 241000948220 Histomonas meleagridis Species 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 208000010362 Protozoan Infections Diseases 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- 208000005448 Trichomonas Infections Diseases 0.000 description 1
- 241000224527 Trichomonas vaginalis Species 0.000 description 1
- 206010044620 Trichomoniasis Diseases 0.000 description 1
- 241001058196 Tritrichomonas foetus Species 0.000 description 1
- 241001442397 Trypanosoma brucei rhodesiense Species 0.000 description 1
- 241000223107 Trypanosoma congolense Species 0.000 description 1
- 241000223109 Trypanosoma cruzi Species 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- 239000000205 acacia gum Substances 0.000 description 1
- 235000011054 acetic acid Nutrition 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 239000004599 antimicrobial Substances 0.000 description 1
- 239000003716 antitrichomonal agent Substances 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 239000012876 carrier material Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 239000008298 dragée Substances 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 230000004992 fission Effects 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 230000002070 germicidal effect Effects 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 235000019359 magnesium stearate Nutrition 0.000 description 1
- 239000000155 melt Substances 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- 235000006408 oxalic acid Nutrition 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 229920001515 polyalkylene glycol Polymers 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 150000007659 semicarbazones Chemical class 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000000829 suppository Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 239000002690 trypanocidal agent Substances 0.000 description 1
- 230000000654 trypanocidal effect Effects 0.000 description 1
- 201000002311 trypanosomiasis Diseases 0.000 description 1
- 229940099259 vaseline Drugs 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 239000000080 wetting agent Substances 0.000 description 1
- 238000010626 work up procedure Methods 0.000 description 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| NO246169A NO120035B (enrdf_load_html_response) | 1966-06-10 | 1969-06-13 |
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US55658566A | 1966-06-10 | 1966-06-10 | |
| NO168540A NO118921B (enrdf_load_html_response) | 1966-06-10 | 1967-06-09 | |
| US84007769A | 1969-04-23 | 1969-04-23 | |
| NO246169A NO120035B (enrdf_load_html_response) | 1966-06-10 | 1969-06-13 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO120035B true NO120035B (enrdf_load_html_response) | 1970-08-17 |
Family
ID=27484003
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO246169A NO120035B (enrdf_load_html_response) | 1966-06-10 | 1969-06-13 |
Country Status (1)
| Country | Link |
|---|---|
| NO (1) | NO120035B (enrdf_load_html_response) |
-
1969
- 1969-06-13 NO NO246169A patent/NO120035B/no unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE60121590T2 (de) | Pyrazolderivate | |
| DE69902634T2 (de) | Substituierte aminophenylisoxazolinderivate verwendbar als antimikrobielle agenzien | |
| DE69002341T2 (de) | Pyrimidinyl-piperazinyl-alkyl-azolyl-Derivate mit anxiolytischer und/oder beruhigender Wirksamkeit. | |
| DE69230225T2 (de) | Triazolylierte tertiäre aminverbindungen oder ihre salze | |
| EP0358595B1 (de) | N-Hetaryl-imidazolderivate | |
| DE1695139A1 (de) | Verfahren zur Herstellung von Imidazolderivaten | |
| DE69324141T2 (de) | Substituierte tertiäre amine und deren salze | |
| CH645100A5 (de) | Substituierte 3-aryl-pyrazole und 5-aryl-isoxazole und verfahren zu ihrer herstellung. | |
| JPS6345672B2 (enrdf_load_html_response) | ||
| DE2638552A1 (de) | Thiazolinyl- oder thiazinylbenzimidazolester | |
| EP0050458A2 (en) | 2-Guanidino-4-heteroarylthiazoles and pharmaceutical compositions containing them | |
| DE2828529A1 (de) | Neue 5-phenylpyrazol-derivate, verfahren zu deren herstellung und arzneimittel | |
| EP0363796A1 (de) | Heterocyclische substituierte Alkoxycumarine, Verfahren zu ihrer Herstellung und diese enthaltende therapeutische Mittel | |
| DE2411295A1 (de) | Substituierte benzimidazol-2-carbamatderivate, verfahren zu deren herstellung und diese enthaltende zusammensetzung | |
| EP0323799B1 (de) | Imidazolderivate II | |
| NO120035B (enrdf_load_html_response) | ||
| DE3315797A1 (de) | Substituierte phenyl-2-(1h)-pyrimidinone, verfahren zu ihrer herstellung und ihre verwendung sowie diese verbindungen enthaltende zubereitungen | |
| DE1695189A1 (de) | Verfahren zur Herstellung von Imidazolderivaten | |
| DE1620018B2 (de) | 1-methyl-5-nitroimidazol-derivate, ihre salze mit saeuren, verfahren zu ihrer herstellung und antiparasitaere mittel | |
| US4808727A (en) | Imidazolium hydrogen carbonates | |
| DE68911944T2 (de) | Cardiotonische Alkanoyl- und Aroyloxazole. | |
| DE2348284A1 (de) | Neue imidazole und verfahren zu ihrer herstellung | |
| DD270906A1 (de) | Verfahren zur herstellung neuer imidazolderivate und deren verwendung als pharmazeutische mittel | |
| DE69207597T2 (de) | Lipoxygenase inhibierende tetrahydrobenzazepinderivate | |
| US3277105A (en) | Isoxazoles |